142 related articles for article (PubMed ID: 15220246)
1. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.
Schulze MB; Rimm EB; Shai I; Rifai N; Hu FB
Diabetes Care; 2004 Jul; 27(7):1680-7. PubMed ID: 15220246
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes.
Mantzoros CS; Li T; Manson JE; Meigs JB; Hu FB
J Clin Endocrinol Metab; 2005 Aug; 90(8):4542-8. PubMed ID: 15914524
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
Ahmad Khan H
Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
[TBL] [Abstract][Full Text] [Related]
5. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.
Klüppelholz B; Thorand B; Koenig W; de Las Heras Gala T; Meisinger C; Huth C; Giani G; Franks PW; Roden M; Rathmann W; Peters A; Herder C
Diabetologia; 2015 Oct; 58(10):2269-77. PubMed ID: 26155746
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and future coronary heart disease events among men with type 2 diabetes.
Schulze MB; Shai I; Rimm EB; Li T; Rifai N; Hu FB
Diabetes; 2005 Feb; 54(2):534-9. PubMed ID: 15677512
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.
Kriketos AD; Greenfield JR; Peake PW; Furler SM; Denyer GS; Charlesworth JA; Campbell LV
Diabetes Care; 2004 Aug; 27(8):2033-40. PubMed ID: 15277436
[TBL] [Abstract][Full Text] [Related]
8. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.
Stenvinkel P; Marchlewska A; Pecoits-Filho R; Heimbürger O; Zhang Z; Hoff C; Holmes C; Axelsson J; Arvidsson S; Schalling M; Barany P; Lindholm B; Nordfors L
Kidney Int; 2004 Jan; 65(1):274-81. PubMed ID: 14675060
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
Krakoff J; Funahashi T; Stehouwer CD; Schalkwijk CG; Tanaka S; Matsuzawa Y; Kobes S; Tataranni PA; Hanson RL; Knowler WC; Lindsay RS
Diabetes Care; 2003 Jun; 26(6):1745-51. PubMed ID: 12766104
[TBL] [Abstract][Full Text] [Related]
11. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
[TBL] [Abstract][Full Text] [Related]
12. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?
Gungor N; Bacha F; Saad R; Janosky J; Arslanian S
Diabetes Care; 2005 Mar; 28(3):638-44. PubMed ID: 15735201
[TBL] [Abstract][Full Text] [Related]
13. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
Aburawi EH; AlKaabi J; Zoubeidi T; Shehab A; Lessan N; Al Essa A; Yasin J; Saadi H; Souid AK
PLoS One; 2016; 11(7):e0159808. PubMed ID: 27459718
[TBL] [Abstract][Full Text] [Related]
15. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease.
Jaleel F; Jaleel A; Aftab J; Rahman MA
Clin Chim Acta; 2006 Aug; 370(1-2):76-81. PubMed ID: 16516182
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
von Eynatten M; Schneider JG; Humpert PM; Rudofsky G; Schmidt N; Barosch P; Hamann A; Morcos M; Kreuzer J; Bierhaus A; Nawroth PP; Dugi KA
Diabetes Care; 2004 Dec; 27(12):2925-9. PubMed ID: 15562208
[TBL] [Abstract][Full Text] [Related]
17. Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.
Kim MJ; Yoo KH; Park HS; Chung SM; Jin CJ; Lee Y; Shin YG; Chung CH
Yonsei Med J; 2005 Feb; 46(1):42-50. PubMed ID: 15744804
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum adiponectin with blood lipids, HbA(1)c, and hs-CRP in type II diabetic postmenopausal women.
Goodarzi MT; Babaahmadi-Rezaei H; Kadkhodaei-Eliaderani M; Haddadinezhad S
J Clin Lab Anal; 2007; 21(3):197-200. PubMed ID: 17506484
[TBL] [Abstract][Full Text] [Related]
19. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo.
Schneider JG; von Eynatten M; Schiekofer S; Nawroth PP; Dugi KA
Diabetes Care; 2005 Sep; 28(9):2181-6. PubMed ID: 16123487
[TBL] [Abstract][Full Text] [Related]
20. A selective peroxisome proliferator-activated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeys.
Wagner JD; Shadoan MK; Zhang L; Ward GM; Royer LJ; Kavanagh K; Francone OL; Auerbach BJ; Harwood HJ
J Pharmacol Exp Ther; 2010 Jun; 333(3):844-53. PubMed ID: 20190014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
